Availability and Affordability of Therapeutic Monoclonal Antibodies After the New Medical Reform in Hubei Province, China.
Curr Med Sci
; 42(6): 1325-1333, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36544039
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hospitals, Public
Type of study:
Guideline
/
Health_economic_evaluation
/
Qualitative_research
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Curr Med Sci
Year:
2022
Type:
Article
Affiliation country:
China